Long‐Term Outcomes of Neoadjuvant Therapy Versus Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma

Long‐Term Outcomes of Neoadjuvant Therapy Versus Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma

ABSTRACT Introduction This study aimed to compare the long‐term effects of neoadjuvant therapy and upfront surgery on overall survival (OS) and progression‐free survival (PFS) in patients with resectable pancreatic ductal adenocarcinoma (PDAC). Methods We retrospectively analyzed 202 patients, inclu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kyung In Shin, Min Sung Yoon, Jee Hoon Kim, Won Joon Jang, Galam Leem, Jung Hyun Jo, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Ho Kyoung Hwang, Chang Moo Kang, Seung‐seob Kim, Mi‐Suk Park, Hee Seung Lee, Seungmin Bang
Format:	Article
Language:	English
Published:	Wiley 2024-11-01
Series:	Cancer Medicine
Subjects:	long‐term results neoadjuvant therapy overall survival pancreatic neoplasm progression‐free survival
Online Access:	https://doi.org/10.1002/cam4.70363
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prognostic value of residual cancer burden after neoadjuvant chemotherapy in breast cancer: a comprehensive subtype-specific analysis
by: Soo-Young Lee, et al.
Published: (2025-04-01)

Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world study
by: Jifeng Feng, et al.
Published: (2024-12-01)

Prognostic value of pathological sensitivity for high-risk, localized prostate cancer receiving neoadjuvant hormonal therapy combined with radical prostatectomy
by: Kai Shi, et al.
Published: (2025-12-01)

The role of neoadjuvant chemotherapy of triple-negative breast cancer in St. Petersburg City Clinical Oncological Dispensary
by: A. G. Manikhas, et al.
Published: (2016-09-01)

Disparities in access to anti-HER2 therapies in neoadjuvant chemotherapy: A prognostic analysis based on real-world data comparing Brazil's public and private healthcare systems
by: Marcelo Antonini, et al.
Published: (2025-04-01)

Neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study with 2-year survival analysis
by: Chong-Rui Li, et al.
Published: (2025-07-01)

Evaluating the efficacy of neoadjuvant immunotherapy combined with chemotherapy for stage IIIa non-small cell lung cancer
by: Ruiqiang Song, et al.
Published: (2025-07-01)

Naples Prognostic Score as a Novel Prognostic Prediction Tool for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma After Neoadjuvant Therapy
by: Chen W, et al.
Published: (2025-04-01)

[Comment] Neoadjuvant chemotherapy with oxaliplatin and fluoropyrimidine versus upfront surgery for locally advanced colon cancer: the randomized, phase Ⅲ OPTICAL trial
by: Zhang Muzi
Published: (2024-06-01)

Long-term survival outcomes of neoadjuvant chemotherapy in stage II-III HR+/HER2- breast cancer
by: Jiaxing Liu, et al.
Published: (2025-08-01)

Correlation analysis of tertiary lymphoid structure parameters with the prognosis of patients with locally advanced rectal cancer after neoadjuvant chemotherapy: a retrospective study
by: Yingjian Jiang, et al.
Published: (2025-04-01)

Long‐Term Survival Analysis of Neoadjuvant Chemoradiotherapy Versus Adjuvant Chemoradiotherapy for Locally Advanced Low Rectal Cancer
by: Siyuan Chen, et al.
Published: (2025-08-01)

Impact of germline BRCA1/2 mutations on response to neoadjuvant systemic therapy and prognosis in breast cancer: a propensity score matched cohort study
by: Hyunyou Kim, et al.
Published: (2025-05-01)

Prognostic value of positive lymph node ratio in oral cavity squamous cell carcinoma after neoadjuvant treatment: a retrospective real-world study
by: Sufeng Fan, et al.
Published: (2025-05-01)

NEOADJUVANT CHEMOTHERAPY WITH RADICAL CYSTECTOMY IN THE TREATMENT OF MUSCLE-INVASIVE BLADDER CANCER
by: N. S. Nurgaliev, et al.
Published: (2016-10-01)

COMBINED TREATMENT OF OPERABLE RECTAL CANCER WITH NEGATIVE PROGNOSIS FACTORS: A PROSPECTIVE STUDY
by: S. O. Kochkina, et al.
Published: (2021-08-01)

Long-term effects of neoadjuvant chemotherapy in variant histology locally advanced colon cancer: a propensity score-matched analysis
by: Qiancheng Wang, et al.
Published: (2025-12-01)

Combination of imaging features on pancreatic CT for predicting early recurrence after upfront pancreatoduodenectomy of pancreatic ductal adenocarcinoma
by: Shuanglin Zhang, et al.
Published: (2025-12-01)

Metabolic Syndrome Is Associated With Poor Prognosis in Patients With Breast Cancer Receiving Neoadjuvant Therapy
by: Youzhao Ma, et al.
Published: (2024-12-01)

Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma
by: Jun-Peng Lin, et al.
Published: (2025-08-01)

Long Term Clinical Outcomes of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: A Single Center Study
by: Seong Hyun Koh, et al.
Published: (2024-03-01)

Nodal Downstaging of Esophageal Cancer After Neoadjuvant Therapy: A Cohort Study and Meta‐Analysis
by: Feng Su, et al.
Published: (2025-02-01)

Four-year follow-up from the phase 2 study TD-NICE: neoadjuvant treatment of tislelizumab combined with chemotherapy in resectable esophageal squamous cell carcinoma
by: Yajie Mao, et al.
Published: (2025-08-01)

The relationship between immediate postmastectomy reconstruction modalities and survival benefits in patients with triple negative breast cancer
by: Luyao Dai, et al.
Published: (2023-02-01)

ASSOCIATION OF NKT- AND ACTIVATED CD25<sup>+</sup> PERIPHERAL BLOOD LYMPHOCYTES WITH DISEASE FREE AND OVERALL SURVIVAL OF TRIPLE NEGATIVE BREAST CANCER PATIENTS
by: A. I. Chertkova, et al.
Published: (2020-12-01)

Pretreatment CALLY index as promising novel biomarker in the prediction of surgical and oncological outcomes in esophageal cancer: a multi-center retrospective cohort study
by: Peize Meng, et al.
Published: (2025-05-01)

The Role of Neoadjuvant Surgical Intervention in the Primary and Repeat Treatment of Malignant Brainstem Tumors in Children and Adolescents
by: V. A. Solodkiy, et al.
Published: (2019-06-01)

Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab
by: Jaejun Lee, et al.
Published: (2024-12-01)

Exploring the effects of doxorubicin on survival rates in glioma patients: a comprehensive systematic review
by: Elyar Mahboubi, et al.
Published: (2025-05-01)

The role of temozolomide as adjuvant therapy in glioblastoma management: a systematic review and meta-analysis.
by: Made Agus Mahendra Inggas, et al.
Published: (2025-03-01)

Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - a US multisite study
by: Narendranath Epperla, et al.
Published: (2025-05-01)

Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients
by: Charlotte Maulat, et al.
Published: (2024-11-01)

Does T1c–2N0–1M0 triple negative breast cancer derive a benefit from neoadjuvant chemotherapy?
by: Ruiliang Chen, et al.
Published: (2024-12-01)

Analysis of the dependence of survival in patients with gastric cancer on the location and characteristics of the tumor
by: O. M. Levyk, et al.
Published: (2013-12-01)

The role of Lobectomy in Glioblastoma management: A Retrospective series
by: Christina K. Arvaniti, et al.
Published: (2025-01-01)

Low Serum Cholinesterase Levels Predict Poor Prognosis in Patients with Ovarian Cancer
by: Su H, et al.
Published: (2025-02-01)

Clinical and Survival Insights into Carcinoma Penis: A Retrospective Analysis at a Tertiary Care Facility
by: Santosh Kumar Swain, et al.

Taxanes in adjuvant and neoadjuvant therapy for breast cancer
by: S. V. Limareva
Published: (2014-08-01)

Long-term oncologic outcomes and prognostic factors related to recurrences in pathologic Stage I/II early oral tongue cancer
by: Jin Hye Kwak, et al.
Published: (2025-05-01)

Pathologic complete response and breast cancer survival post-neoadjuvant chemotherapy: A systematic review and meta-analysis of real-world data
by: Marcelo Antonini, et al.
Published: (2025-05-01)